What is Corbus Pharmaceuticals Holding?
, a clinical stage company, develops and commercializes therapeutics for cancer and obesity.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 42.45M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 2427,000 shares $1.8M | 0 |
| 3-6months | 538,238 shares $365k | 316,100 shares $126k |
| 6-9months | 16,097 shares $51k | 0 |
| 9-12months | 655,148 shares $541k | 0 |